Nail Paksoy

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Prognostic Factors

Ejection Fraction

Renal Cell Carcinoma

Top Venues

Turkish journal of medical sciences

European journal of breast health

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Nail Paksoy, Nijat Khanmammadov, İzzet Doğan, Ferhat Ferhatoğlu, Melin Aydan Ahmed, Sule Karaman, Adnan Aydiner
Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study. Medicine 102 (5) (2023)
Nail Paksoy, Nijat Khanmammadov, İzzet Doğan, Ferhat Ferhatoğlu, Melin Aydan Ahmed, Sule Karaman, Adnan Aydiner
Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study. Medicine 102 (5) (2023)
Nail Paksoy, Ferhat Ferhatoglu, İzzet Dogan, Nijat Khanmammadov, Ayca Iribas Celik, Zafer Gulbas, Mert Başaran
High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience. Medicine 101 (49) (2023)
Naziye Ak, Zeynep Tuz, Esra Aydin, Ferhat Ferhatoglu, Murat Sarı, Nail Paksoy, Izzet Dogan, Anıl Yıldız, Rian Dişçi, Pınar Mualla Saip
The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients. Turkish journal of medical sciences 54 (1) (2023)
Izzet Dogan, Nail Paksoy, Sezai Vatansever, Adnan Aydıner
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine. European journal of breast health 19 (2) (2023)
Izzet Dogan, Esra Aydin, Ni Jat Khanmammadov, Nail Paksoy, Pınar Mualla Saip, Adnan Aydıner
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression. Scientific reports 13 (1) (2023)
Naziye Ak, Zeynep Tuz, Esra Aydin, Ferhat Ferhatoglu, Murat Sarı, Nail Paksoy, Izzet Dogan, Anıl Yıldız, Rian Dişçi, Pınar Mualla Saip
The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients. Turkish journal of medical sciences 54 (1) (2023)
Nail Paksoy, Ferhat Ferhatoglu, İzzet Dogan, Nijat Khanmammadov, Ayca Iribas Celik, Zafer Gulbas, Mert Başaran
High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience. Medicine 101 (49) (2023)
Nail Paksoy, Nijat Khanmammadov, İzzet Doğan, Ferhat Ferhatoğlu, Anil Yildiz, Naziye Ak, Adnan Aydiner
Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study. Medicine 101 (45) (2022)
Seval Ay, Muhammet Mustafa Atcı, Rukiye Arıkan, Ozgecan Dulgar, Deniz Tataroğlu Özyükseler, Nail Paksoy, Izzet Dogan, Buğra Öztosun, Didem Taştekin, Bala Başak Öven, Mahmut Gümüş
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. Journal of chemotherapy (Florence, Italy) 34 (7) (2022)
Nail Paksoy, Selcuk Erdem, Mert Karaca, Naziye Ak, Metin Pehlivan, Inci K Yirgin, Yasemin Ozluk, Feza Ekiz, Deniz Tural, Meltem Ekenel, Faruk Ozcan, Mert Basaran
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (1) (2021)
Ibrahim Cil, Ahmet Küçükarda, Muhammed Mustafa Atcı, Saban Secmeler, Nail Paksoy, Ferhat Ferhatoglu, Naziye Ak, Murat Ayhan, Deniz Tataroglu Ozyukseler, Arif Hakan Onder, Okan Avcı, Abdilkerim Oyman, Ilker Nihat Okten, Ilkay Gulturk, Baran Akagunduz, Tugba Basoglu, Emre Cakir, Ilhan Hacibekiroglu, Melike Ozcelik, Adnan Aydiner
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori (2021)